EL7.AI
Strategy BuilderCOT DataAdvanced NewsResearchNewEarnings CalendarEconomic Calendar
We use cookiesPrivacy Policy
EL7.AIEL7.AI

AI Financial Intelligence
Professional analysis of central bank decisions

© 2026 EL7.AI. All rights reserved.

Markets

  • News
  • Forex
  • Stocks
  • Crypto
  • Gold
  • Commodities
  • Indices
  • ETFs

Analysis

  • Fed
  • ECB
  • BLS
  • COT
  • Economic Calendar

Learn

  • Service Guide
  • Oil

Company

  • About
  • Contact
  • Data Methodology
  • AI Disclosure
  • Pricing
  • Enterprise
  • Terms
  • Privacy
  • Security
  • WhatsApp
Status data is currently unavailable

The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

Home
Stocks
Astera Labs, Inc. Common Stock
EL7 Factor Analysis
How we score this
Overall93
Excellent — top fifth of the marketHigh FlyerF 5/9Better than 93% of Market stocks, per EL7's model
FactorScoreDistributionValueAvgRank
▸
Valuation
6
140.0x▼17.8xBottom tier
▸
Growth
98
98.5%▲7.1%Top tier
▸
Quality
88
21.9%▲4.5%Top tier
▸
Safety
94
—2.6xTop tier
▸
Capital Return
64
—2.12%Around median
▸
Momentum
76
85.1%▲2.9%Top tier
▸
Sentiment
45
15▲3Around median
ALAB

ALAB Astera Labs, Inc. Common Stock

Astera Labs, Inc. Common Stock · NASDAQ
Market Closed
291.22
▲ ⁦+2.35%⁩ (+6.69)
Market Cap$49.9B
Beta3.84
52w Low52w High
97.89499.48
Last Week
⁦+2.97%⁩
Last Month
⁦-12.85%⁩
Last 3 Months
⁦-10.48%⁩
Last Year
⁦+67.22%⁩
Fair Value
Current price$291
Analyst target · 7 analysts
$388
⁦+33%⁩
See it clearly undervalued
Range ⁦$153–$500⁩
vs
DCF (estimate)
$29
⁦-90%⁩
Sees it clearly overvalued
⁦13.3⁩% discount · ⁦12⁩% growth
Bottom lineThe two methods disagree — estimate range ⁦$29–$388⁩.

Estimates — analyst targets and a simplified DCF, not investment advice.

Compare in the screener
Premium content

Get Your Premium Account Now

  • Stock Deep Analysis
  • The Advanced News Platform
Recommended
Annual plan
$17/mo
Monthly plan
$29/mo

Analyst Consensus

This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.

Price Target· 7 analysts setting price target
$370.42
⁦+27.2%⁩
Current Price $291.22·Median $387.50
Low
$153.00
High
$500.00
Current price
$291.22
Average target
$370.42
Street summary

Astera Labs (ALAB) Price Target Revision Analysis

Bullish tilt

Astera Labs stock has seen a sharp upward revision in its average price target over the past thirty days, with the consensus jumping by 34.04% to rise from $277.73 to $372.27, reflecting increasing optimism from the seven analysts covering the stock. However, there is significant dispersion in estimates, with the price range spanning from a low of $153 to an ambitious high of $500, indicating a divergence in views regarding the stock's fair value despite the stability of ratings in the last week.

As of 2026-08-12
Revisions momentum · 30d
⁦-0.5%⁩
Average rating
★ 4.00
Buy
Analyst coverage
26
Buy conviction
73%
High
Target dispersion
119%
Wide
Analyst ratings over time26 analysts rating
7
12
7
Strong BuyBuyHoldSellStrong Sell
Rating trend — last 12 months3.96 → 4.00
Recent analyst moves
  • = Reiterate2026-08-05
    TD Cowen
    Hold
  • = Reiterate2026-08-05
    Jefferies
    Buy
  • = Reiterate2026-08-05
    Roth MKM
    Buy
Premium content
Key Financials

Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.

StockSector medianSector averagetypical sector range
MetricValuePosition within sectorVerdict
  • P/E (TTM)
    140.01x
    6.87x54.92x
    Very expensive
  • Forward P/E
    77.85x
    5.19x41.53x
    Very expensive
  • EV / EBITDA
    177.24x
    4.52x36.15x
    Very expensive
  • FCF Yield
    0.6%
    -54.8%10.8%
    Strong
  • Revenue Growth YoY
    98.5%
    -18.1%66.5%
    Exceptional
  • EPS Growth YoY
    264.9%
    -155.3%193.7%
    Exceptional
  • Gross Margin
    75.1%
    12.9%79.5%
    Strong
  • ROIC
    21.9%
    -63.6%26.5%
    Strong
  • Net Debt / EBITDA
    —
    —
  • Dividend Yield
    —
    —
  • Payout Ratio
    —
    —
  • Altman Z-Score
    —
    —
Financial Analysis
|

Stock Analysis

AI-generated
Based on 2026-08-04 data

Company Overview

Astera Labs develops intelligent connectivity solutions for AI infrastructure and data centers, generating revenue from multiple product families, including Scorpio fabric switches, Aries retimers, Taurus connectivity solutions, and Leo memory controllers. These products are designed to connect AI accelerators, processors, and servers through technologies such as PCIe 6.0, Ethernet, and CXL, while the COSMOS platform adds management, diagnostics, traffic shaping, and workload orchestration capabilities.

In fiscal Q2 2026, Astera Labs reported record revenue of $392.4 million, up 27% sequentially and 104% year over year. PCIe 6.0 products accounted for more than 50% of revenue, compared with approximately one-third in fiscal Q1 2026, and Aries generated record quarterly revenue, while Scorpio growth accelerated with the start of initial production-volume shipments of Scorpio X-Series, and Taurus posted strong growth in units shipped.

Non-GAAP gross margin was approximately 73.7% in fiscal Q2 2026, exceeding the company’s guidance of 73%, and non-GAAP operating margin increased by 290 basis points sequentially to 39.1%. Non-GAAP net income was approximately $145.8 million, and diluted earnings per share were $0.80, while EDGAR data for the twelve-month period ending in 2026 show revenue of $1 billion and net income of $267.6 million.

What's Driving the Stock

  • Management expects revenue of between $540 million and $560 million in fiscal Q3 2026; the midpoint of $550 million implies sequential growth of approximately 40%, driven by the production ramp of Scorpio X-Series, continued strength in Aries PCIe 6.0, and initial Taurus shipments for 800G solutions.
  • Scorpio X-Series has entered volume production, and the company expects the Scorpio family to become its largest product line by revenue in fiscal Q3 2026, one quarter earlier than previously expected. The company has more than ten customers engaged with Scorpio X, with qualification shipments to several customers and expectations of adding revenue-generating customers by the end of 2026.
  • The Hyper-cast and in-network computing features in Scorpio X enable up to a twofold improvement in collective-operations performance for training and inference workloads. Management believes the Scorpio X content opportunity alone could exceed $1,000 per XPU in future generations as port counts, switch capabilities, and connectivity architecture complexity increase.
  • Astera Labs expanded the Taurus family with 3.2T solutions operating at 200G per lane to support Ethernet and UALink, and expects these products to double the addressable market for the Taurus family to more than $4 billion by 2030. In fiscal Q2 2026, it also began shipping pre-production volumes of smart cable modules operating at 100G per lane for 800G AEC applications.
  • In fiscal Q2 2026, the company secured a new design win for the standard Leo module at a large U.S. cloud service provider. In 2027, it expects to ship standard and custom Leo modules in production volumes to large U.S. providers for general-purpose computing and AI inference.
  • The optical connectivity roadmap targets the start of production for a fiber solution for a tier-one provider and NPO solutions in 2027, followed by Scorpio X switches equipped with CPO engines in 2028 and beyond. The company has built capabilities in analog and mixed-signal design, DSP, electronic and photonic circuit integration, and optical packaging through internal investment and the acquisition of aiXscale.

Buying & Selling Case

▲ Buying Case4 pts

  • +Fiscal Q2 2026 combines 104% year-over-year revenue growth with high operating profitability; non-GAAP operating margin reached approximately 39.1%, and management expects it to rise to nearly 43% in fiscal Q3 2026 as revenue grows.
  • +The company’s growth is now distributed across Scorpio, Aries, and Taurus rather than relying on only one product; Aries posted a quarterly record, Scorpio X entered volume production, and Taurus shipments grew across AI and general-purpose computing platforms.
  • +The product roadmap gives Astera Labs multiple expansion opportunities beyond 2026, including UALink, CXL, optical connectivity, and custom solutions. Specific milestones include shipments of Scorpio solutions supporting UALink in 2027, production of Leo modules at large U.S. providers in 2027, and a target for NPO in the same year.
  • +Cash, cash equivalents, and marketable securities totaled $1.25 billion at the end of fiscal Q2 2026, providing the company with resources to fund its product roadmap and invest in high-speed connectivity solutions.

▼ Selling Case5 pts

Valuation

The analyst consensus is “Buy,” with an average price target of $370.42 and a wide range extending from $153 to $500; the average target is below the 52-week high of $499.476, while the highest target nearly matches that level. The substantial difference between the low and high estimates reflects a fundamental divergence in assessments of Scorpio’s expansion pace and the sustainability of margins, despite Jefferies raising its target to $450 following the fiscal Q2 2026 results. No displayed P/E ratio is available, so the available valuation assessment is based on the market capitalization of $51.7 billion relative to revenue growth and on the 52-week range of $97.89–$499.476.

BuyAnalyst target: $370.42(+27.2%)

Figures in the text are as of 2026-08-27; the live price is shown at the top of the page.

FAQ

What drove Astera Labs’ growth in fiscal Q2 2026?

Revenue increased to $392.4 million, growing 27% sequentially and 104% year over year. Growth came from broad strength across Scorpio, Aries, and Taurus, rather than from only one product line. PCIe 6.0 products accounted for more than half of revenue, up from approximately one-third in fiscal Q1 2026. Scorpio X-Series also began initial production-volume shipments, while Aries posted record quarterly revenue.

Why is Scorpio X-Series central to the ALAB story?

Scorpio X-Series has entered volume production, and management expects the Scorpio family to become the company’s largest product line by revenue in fiscal Q3 2026. The switches support high-port-count configurations and include Hyper-cast and in-network computing features that may improve collective-operations performance by up to twofold. The company has more than ten customers engaged with Scorpio X, with revenue-generating shipments to additional customers expected by the end of 2026. Management believes Scorpio X content alone could exceed $1,000 per XPU in future generations.

What is Astera Labs’ guidance for fiscal Q3 2026?

The company expects revenue of between $540 million and $560 million, with the midpoint representing sequential growth of approximately 40%. It expects non-GAAP diluted earnings per share of between $1.16 and $1.21 and an operating margin of approximately 43%. In contrast, it expects non-GAAP gross margin to decline to approximately 72% from 73.7% in fiscal Q2 2026. The outlook is based on Scorpio X-Series production, strength in Aries PCIe 6.0, and Taurus shipments supporting 800G.

Earnings callEDGAR filings30-day newsInsider activity

Automated analysis for informational purposes only — not investment advice.

−
Achieving fiscal Q3 2026 guidance depends significantly on Scorpio X-Series transitioning to volume production at the primary opportunity and customer, with Scorpio X revenue expected to exceed Scorpio P revenue during that quarter. Although more than ten customers are engaged with Scorpio X, many other programs remain in qualification or pre-production, making the timing of their actual ramp a material execution risk.
  • −Management expects non-GAAP gross margin to decline from 73.7% in fiscal Q2 2026 to approximately 72% in fiscal Q3, then trend toward 70% over the long term. This is related to the broader product mix and differences in margins across silicon, modules, Scorpio use cases, and the number of lanes utilized.
  • −The company faces a technology race in the PCIe, Ethernet, and UALink markets; management noted that other suppliers have announced UALink products, while Astera Labs plans to introduce Scorpio X solutions supporting the protocol in 2027. Therefore, maintaining differentiation depends on executing the PCIe 7.0, UALink, and optical connectivity roadmaps according to the timelines customers require.
  • −Analyst valuations vary widely, with price targets ranging from $153 to $500, while the stock’s 52-week range extends from $97.89 to $499.476. This breadth, together with a market capitalization of $51.7 billion and the absence of a displayed P/E ratio, indicates high sensitivity to any slowdown in revenue growth or disruption to the expected Scorpio ramps.
  • −Net insider transactions during the three months ending with the latest transaction on August 17, 2026, totaled negative $346.5 million, with 183 sales and no purchases recorded. This is a weak trading signal on its own because insider sales may be prearranged, and the available information contains no evidence to the contrary.
  • What opportunities does Astera Labs have in CXL and optical connectivity?

    In fiscal Q2 2026, Astera Labs secured a design win for the standard Leo module at a large U.S. cloud service provider. It expects to ship standard and custom Leo modules in production volumes to large U.S. providers in 2027 for general-purpose computing and inference applications. In optical connectivity, the company is targeting production of a fiber solution for a tier-one provider and NPO solutions in 2027. Scorpio X switches integrated with optical CPO engines are part of the roadmap for 2028 and beyond.

    Can Astera Labs maintain its margins as Scorpio grows?

    Non-GAAP gross margin was approximately 73.7%, and operating margin was 39.1% in fiscal Q2 2026. For fiscal Q3, management expects gross margin of approximately 72%, while operating margin rises to approximately 43% due to operating leverage. The CFO explained that Scorpio’s average margin across use cases is generally close to the company’s margin, but the mix changes according to product type and the number of lanes utilized. Over the long term, management expects gross margin to trend toward 70%.

    What are the main ALAB stock risks to monitor?

    The first risk is fiscal Q3 2026 guidance’s reliance on the rapid ramp of Scorpio X production at the primary customer and opportunity, while other programs remain in qualification or pre-production. The second is the expected decline in non-GAAP gross margin from 73.7% in fiscal Q2 to approximately 72% in fiscal Q3, with a long-term target of approximately 70%. The UALink market is also competitive, and management acknowledged that other suppliers have announced products, while Astera Labs is targeting 2027 for its supporting solutions. Finally, the divergence in analyst targets between $153 and $500, together with the 52-week range of $97.89–$499.476, reflects a high degree of valuation uncertainty. claims.